SNOMED CT
Potential Case for Investment
SNOMED CT Break-Even Analysis
Potential mean savings of USD$58.25 billion per year in improved inpatient and outpatient services. Using only the Model 1 cumulative benefits of USD$875B the breakeven percentage is 0.01%.
Over 750,000 reduced bed days, approximately 85,000 reduced workdays missed and over 2,200 deaths avoided from immunizations, and over 3700 deaths avoided and 50,000 life-years gained from cancer screening.
Cost savings from improvements in inpatient nursing time, lab tests, drug utilization, length of stay and medical records; plus outpatient transcription use, chart pulls, lab/radiology tests, & drug utilization.
A Benefits to Cost Multiple of 1.8 - 4.1 and an Internal Rate of Return for the same investment of 10-41%. from investing in clinical information systems and interoperability solutions.
The average annual increase to U.S. GNI as a result of the investments in clinical information systems and interoperability solutions was 0.23% or USD$30.71 billion.
Cost savings from improvements in inpatient nursing time, lab tests, drug utilization, length of stay and medical records; plus outpatient transcription use, chart pulls, lab/radiology tests, & drug utilization.
Cost savings from improvements in inpatient nursing time, lab tests, drug utilization, length of stay and medical records; plus outpatient transcription use, chart pulls, lab/radiology tests, & drug utilization.
Cost savings from improvements in inpatient nursing time, lab tests, drug utilization, length of stay and medical records; plus outpatient transcription use, chart pulls, lab/radiology tests, & drug utilization.
Cost savings from improvements in inpatient nursing time, lab tests, drug utilization, length of stay and medical records; plus outpatient transcription use, chart pulls, lab/radiology tests, & drug utilization.
The average annual increase to a nation’s GNI as a result of the investments in clinical information systems and interoperability solutions